MEP including Acoustic Consultant/BSL3 Laboratory - Full and complete service for the duration of the project life cycle Validation Centre
This is a contract result notice, not an open opportunity. Details from the official award data.
This sits in the lower-middle of the Construction band — a mid-scale opportunity. Based on 64,002 valued Construction tenders in our corpus.
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers.
Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products.
By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
Capitalising on the success of the Lighthouse Lab to create a new BSL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain.
The project will create a national facility for testing and validation of new diagnostics, biomarkers and innovative therapeutics for disease.
The Validation Centre of Excellence will enable innovators to set up new companies with confidence, driving regional growth in high-value jobs and a sector of urgent national and global need.
What the notice asks for
By sharing problems, rare expertise and assets
By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
Capitalising on the success of the Lighthouse
Capitalising on the success of the Lighthouse Lab to create a new BSL3 facility for innovative diagnostics, biomarkers and complex medicines and develop the UK's onshore diagnostic capability and capacity and the associated supply chain.
Sentences from the notice that state an obligation, surfaced automatically and shown in the order they appear. Not an exhaustive list — always confirm against the tender documents.
Make the case to bid
Reveal who to approach at Medicines Discovery Catapult, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- 56268b4a-af27-42d0-9aaf-3541a1335122
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- MEDDISC001-DN554695-28712316
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Construction
Medicines Discovery Catapult’s tender network